ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
MoonLake Immunotherapeutics

MoonLake Immunotherapeutics (MLTX)

52,17
0,29
(0,56%)
Fermé 22 Décembre 10:00PM
52,08
-0,09
(-0,17%)
Après les heures de négociation: 1:59AM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
52,17
Prix Achat
50,50
Prix Vente
56,82
Volume échangé
192 786
50,21 Fourchette du Jour 54,10
37,55 Plage de 52 semaines 64,98
Cap du marché
Clôture Veille
51,88
Ouverture
51,71
Dernière Transaction
1
@
52.5
Dernière heure de transaction
Volume financier
US$ 10 171 326
VWAP
52,7597
Volume moyen (3 m)
278 431
Actions en circulation
63 905 198
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-75,50
Bénéfice par action (BPA)
-0,69
Chiffre d'affairess
-
Bénéfice net
-44,08M

À propos de MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

Secteur
Blank Checks
Industrie
Pharmaceutical Preparations
Site Web
Siège social
Grand Cayman, Cym
Fondé
2020
MoonLake Immunotherapeutics est coté dans le secteur Blank Checks de la NASDAQ avec le ticker MLTX. Le dernier cours de clôture d'MoonLake Immunotherapeut... était de US$51,88. Au cours de la dernière année, les actions de MoonLake Immunotherapeut... ont été négociées dans une fourchette de prix de US$ 37,55 à US$ 64,98.

MoonLake Immunotherapeut... compte actuellement 63 905 198 actions en circulation. La capitalisation boursière d'MoonLake Immunotherapeut... est de US$3,32 milliard. MoonLake Immunotherapeut... a un ratio cours/bénéfice (ratio PE) de -75.50.

MLTX Dernières nouvelles

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis Two trials for active psoriatic arthritis (PsA) with one focusing...

MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update

MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update Ended the third quarter with $493.9 million in cash, cash equivalents and short-term...

MoonLake Immunotherapeutics to host a Capital Markets Update on Wednesday, September 11

MoonLake Immunotherapeutics to host a Capital Markets Updateon Wednesday, September 11 ZUG, Switzerland, September 9, 2024 – MoonLake Immunotherapeutics AG (“MoonLake”; Nasdaq: MLTX), a...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-1.7-3.1557453127953.8758.2650.426249053.28743755CS
4-0.13-0.24856596558352.358.2650.419165153.5570256CS
120.591.1438542070651.5858.2645.2427843151.13413368CS
2612.8732.748091603139.358.2637.5530549248.14058829CS
52-7.1-11.97907879259.2764.9837.5535759349.14812194CS
15639.8321.74616006512.3764.984.2534448443.00417947CS
26039.8321.74616006512.3764.984.2534448443.00417947CS

MLTX - Frequently Asked Questions (FAQ)

What is the current MoonLake Immunotherapeut... share price?
The current share price of MoonLake Immunotherapeut... is US$ 52,17
How many MoonLake Immunotherapeut... shares are in issue?
MoonLake Immunotherapeut... has 63 905 198 shares in issue
What is the market cap of MoonLake Immunotherapeut...?
The market capitalisation of MoonLake Immunotherapeut... is USD 3,32B
What is the 1 year trading range for MoonLake Immunotherapeut... share price?
MoonLake Immunotherapeut... has traded in the range of US$ 37,55 to US$ 64,98 during the past year
What is the PE ratio of MoonLake Immunotherapeut...?
The price to earnings ratio of MoonLake Immunotherapeut... is -75,5
What is the reporting currency for MoonLake Immunotherapeut...?
MoonLake Immunotherapeut... reports financial results in USD
What is the latest annual profit for MoonLake Immunotherapeut...?
The latest annual profit of MoonLake Immunotherapeut... is USD -44,08M
What is the registered address of MoonLake Immunotherapeut...?
The registered address for MoonLake Immunotherapeut... is P.O. BOX 309, UGLAND HOUSE, GRAND CAYMAN, 1104
What is the MoonLake Immunotherapeut... website address?
The website address for MoonLake Immunotherapeut... is moonlaketx.com
Which industry sector does MoonLake Immunotherapeut... operate in?
MoonLake Immunotherapeut... operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,32M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
305,1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
292,16M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
287,21M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
277,63M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées